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ABSTRACT
Although RNA interference (RNAi) is a popular
technique, no method for simultaneous silencing
of multiple targets by small-hairpin RNA (shRNA)-
expressing RNAi vectors has yet been established.
Although gene silencing can be achieved by syn-
thetic small-interfering RNA (siRNA) duplexes, the
approach is transient and largely dependent on the
transfectionefficiencyofthehostcell.Weofferasolu-
tion: a simple, restriction enzyme-generated stable
RNAi technique that can efficiently silence multiple
targets with a single RNAi vector and a single selec-
tion marker. In this study, we succeeded in simulta-
neous stable knockdown of transforming growth
factor b (TGF-b) pathway-related Smads—Smad2,
Smad3andSmad4—atthecellularlevel.Weobserved
distinct phenotypic changes in TGF-b-dependent
cellular functions such as invasion, wound healing
and apoptosis. This method is best suited for an
analysis of complex signal transduction pathways
in which silencing of a single gene cannot account
for the whole process.
INTRODUCTION
Transforming growth factor b (TGF-b) is a multipotent
cytokine that delivers mainly cytostatic signals (1). TGF-b
signals via the receptor complex of TGFBR2 and TGFBR1,
and Smad transcription factors mediate the growth inhibitory
effect of TGF-b in many cell types. The TGF-b cytostatic
response is of interest because its loss contributes to tumor
development. Various genetic and epigenetic alterations of the
components of the TGF-b–Smad pathwayhave been identiﬁed
in several human cancers (2–4).
Although synthetic small-interfering RNA (siRNA)
duplexes can be used for loss of function analysis of the
pathway, the establishment of stable knockdown cell lines
whose targets are silenced by the integration of a siRNA
expression unit by plasmid vectors have various advantages
for such purposes. First, the knockdown efﬁciency of synthetic
siRNA duplexes is largely dependent on the transfection efﬁ-
ciency of the host cell line. We optimize the efﬁcacy when we
transfect plasmids expressing siRNA; however, we do not
need to introduce a plasmid into the majority of cells, as
with synthetic siRNA duplexes. Second, the transient nature
of siRNA duplexes makes it difﬁcult to silence some targets
with long half-lives. Third, most transfection methods are
cytotoxic,which makesitdifﬁculttoobserveimportantpheno-
typic changes like cell death, apoptosis and cell growth by
transient transfection assay (5). The establishment of stable
knockdown cell lines whose targets are silenced permanently
by plasmid vectors could overcome these problems.
Although tandem-type U6 promoter-driven siRNA vectors
expressing each strand of siRNA separately are sufﬁcient for
silencing endogenous gene expression (6), we used hairpin-
type siRNA expression vectors because they proved to be
better suppressors (7). Although we previously reported the
functional analysis of Smad4 using hairpin-type single stable
RNA interference (RNAi) to analyze a complex signal trans-
duction pathway (8,9), it is sometimes desirable to knock
down several genes simultaneously. To meet this challenge,
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doi:10.1093/nar/gni130we positioned tandem U6-driven short-hairpin RNAs targeting
different genes. The particular properties of this system
allow the efﬁcient, stable and simultaneous knockdown of
multiple genes.
MATERIALS AND METHODS
siRNA design and construction
Four different sequences targeting the Smad2, Smad3 or
TGFBR2 genes were selected using the original algorithm
(7). To improve the silencing activity and to overcome tech-
nical obstacles described in the text, multiple C to T or A to G
mutations were introduced within the sense strand of the hair-
pin loop. To construct hairpin-type single RNAi vectors, 5 ml
(100 mM)ofthe synthesized (Qiagen, Hilden, Germany) sense
and antisense oligonucleotides (Table 1) were combined with
1mlof1MNaClandannealedbyincubationat95 Cfor2min,
followed by rapid cooling to 72 C, and ramp cooling to 4 C
over a period of 2 h. We diluted the annealed oligonucleotides
200-fold with TE buffer, and used 1 ml for ligation with
plasmid DNA, which was prepared as follows: 3–5 mgo f
pcPUR+U6i cassette plasmid was digested with BspMI in a
reaction volume of 100 ml. The reaction mixture was elec-
trophoresed, gel pieces containing the DNA fragments were
excised and the DNA was puriﬁed using a MinElute Gel puri-
ﬁcation kit (Qiagen). After ligation with DNA Ligation Kit
Ver.2.1 (Takara, Tokyo, Japan), we transformed Escherichia
coli host cells with the ligation products. A Smad2 and -3
double-knockdown construct was generated as follows:
pcPUR+U6-Smad2i was digested with BamHI and ScaI,
and pcPUR+U6-Smad3i was digested with ScaI and BglII
(Step 1 in Figure 1C). The fragments containing the U6 pro-
moterandhairpinloopunitswerepuriﬁed(Step2inFigure1C)
and ligated to construct the double-knockdown vector (Step 3
in Figure 1C). Sites produced by BglII and BamHI are cohe-
sive, but cannot be cut after ligation; consequently, the same
procedure can be repeated to construct a vector with multiple
siRNAs. The ScaI site is in the ampicillin-resistance gene,
which reduces the number of background bacterial colonies.
The same method was applied to other double- or triple-
knockdown constructs (Figure 1D). The pcPUR+U6i cassette
was provided by iGENE Therapeutics (Tsukuba, Japan);
pcPUR+U6iGFP and pcPUR+U6-Smad4i were described
previously (6,9); pCMV5-TGFb RII/HA was provided by
J.L. Wrana; pcDEF3-Flag(N)-Smad2 and pcDEF3-Flag(N)-
Smad3 were gifts from K. Miyazono; (CAGA)9-luc (10)
was a gift from S.E. Kern; and p3TP-Lux was a gift from
J. Massague. pRL-SV40 (Promega, Madison, WI), which con-
tains the simian virus 40 promoter upstream of the coding
sequence of Renilla luciferase, was used as the internal control
in the luciferase assay.
Cell culture and transfection
The HeLa cell line was purchased from the American Type
Culture Collection (Rockville, MD) and was maintained in
DMEM containing 10% fetal bovine serum (FBS) (Sigma,
St Louis, MO). The human keratinocyte cell line HaCaT
was generously provided by N.E. Fusenig (DKFZ, Heidelberg,
Germany) and was maintained in DMEM containing 10%
FBS. Transfections were performed using Effectene (Qiagen),
according to the manufacturer’s instructions. To establish
cell lines stably expressing siRNAs, we transfected siRNA
plasmids into HaCaT cells, and cultured cells in the presence
of 1 mg/ml of puromycin. Colonies resistant to puromycin
appeared within 2 weeks, after which the cells were expanded
for another 3 weeks to make the original stock cells. The
expression of endogenous Smads or siRNA in the original
stock and cells after 20 passages was examined using western
or northern blotting, respectively. All biological assays
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Table 1. siRNAs targeting TGFBR2, Smad2 and Smad3
TGFBR2 site 1 sense 50-caccatgagtaattgtagtatcaccgtgtgctgtccggtgatgctgcagttgctcatttttt-30
antisense 50-gcataaaaaatgagcaactgcagcatcaccggacagcacacggtgatactacaattactcat-30
site 2 sense 50-caccaggctaagttgaagtagaacagtgtgctgtcctgttctgcttcagcttggcctttttt-30
antisense 50-gcataaaaaaggccaagctgaagcagaacaggacagcacactgttctacttcaacttagcct-30
site 3 sense 50-caccacggttctctaaatactaccagtgtgctgtcctggtagtgtttagggagccgtttttt-30
antisense 50-gcataaaaaacggctccctaaacactaccaggacagcacactggtagtatttagagaaccgt-30
site 4 sense 50-caccaaggatgtcttcttagatatcgtgtgctgtccgatgtctgagaagatgtccttttttt-30
antisense 50-gcataaaaaaaggacatcttctcagacatcggacagcacacgatatctaagaagacatcctt-30
Smad2 site 1 sense 50-caccggattgagctttatttgaatggtgtgctgtcccattcagatgaagttcaatccttttt-30
antisense 50-gcataaaaaggattgaacttcatctgaatgggacagcacaccattcaaataaagctcaatcc-30
site 2 sense 50-caccggcttgatctttatagttatcgtgtgctgtccgatgactgtgaagatcaggccttttt-30
antisense 50-gcataaaaaggcctgatcttcacagtcatcggacagcacacgataactataaagatcaagcc-30
site 3 sense 50-caccggtttactttctagtgttaacgtgtgctgtccgttaacattggagagtaaaccttttt-30
antisense 50-gcataaaaaggtttactctccaatgttaacggacagcacacgttaacactagaaagtaaacc-30
site 4 sense 50-caccgccacttcttggatatattaggtgtgctgtccctgatatatccaggaggtggcttttt-30
antisense 50-gcataaaaagccacctcctggatatatcagggacagcacacctaatatatccaagaagtggc-30
Smad3 site 1 sense 50-caccggccagacttgtatagctaccgtgtgctgtccggtggctgtgcaggtctggccttttt-30
antisense50-gcataaaaaggccagacctgcacagccaccggacagcacacggtagctatacaagtctggcc-30
site 2 sense 50-caccggattgagttgtatctgaatggtgtgctgtcccattcaggtgcagctcaatccttttt-30
antisense 50-gcataaaaaggattgagctgcacctgaatgggacagcacaccattcagatacaactcaatcc-30
site 3 sense 50-caccgagtttgtctttaatatgaaggtgtgctgtcccttcatattgaaggcgaactcttttt-30
antisense 50-gcataaaaagagttcgccttcaatatgaagggacagcacaccttcatattaaagacaaactc-30
site 4 sense 50-caccgggttgttcttcaatgttaacgtgtgctgtccgttgacattggagagcagcccttttt-30
antisense 50-gcataaaaagggctgctctccaatgtcaacggacagcacacgttaacattgaagaacaaccc-30
siRNAtargetsequencesarenotunderlined;mutatedsequencesareinitalics;theloopsequenceisunderlined;thetranscriptionstopcodonisdoubleunderlined;andthe
BspMI site is indicated by a dotted underline.
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the original cell stock.
Western blot
Western blotting was performed as described previously (11).
Equal amounts of protein were electrophoresed, and the pro-
teins were detected using the anti-Smad2/3 or anti-Smad4
antibody (BD Transduction Laboratories, San Diego, CA)
at a dilution of 1:250, the anti-b-actin or anti-Flag antibody
(Sigma) at a dilution of 1:2500, or the anti-HA antibody
(Roche Molecular Biochemicals, Indianapolis, IN) or anti-
PAI-1 antibody (BD Transduction Laboratories) at a dilution
of 1:1000.
Northern analysis
Total RNA was extracted from the stable knockdown cells
using Isogen Reagent (Wako, Tokyo, Japan). The total
RNA (5 mg) was size-fractionated on an 18% (wt/vol)
Figure 1. RNAivectorconstruction.(A)FourtargetsitesforeachoftheSmad2,Smad3orTGFBR2genesweredesignedandsubclonedintopcPUR+U6-icassettes,
which were transiently cotransfected with the Smad2-, Smad3- or TGFBR2-expressing vectors into HeLa cells, to screen the silencing efficacy by western blot
analysis. The same samples were loaded in duplicate. (B) Specific knockdown of Smad2 or -3. HaCaT cells were transiently transfected with pcDEF3-Flag(N)-
Smad2, pcDEF3-Flag(N)-Smad3 and pcPUR+U6-Smad2i (left lane), pcPUR+U6-Smad3i (middle lane) or pcPUR+U6-GFPi (right lane). After lysing the cells, we
performedwesternblotanalysis.(C)Restrictionenzyme-basedgenerationofmulti-targetsiRNAvectors.ThepcPUR+U6-icassettehasrestrictionenzymesitesfor
BglII upstream of the U6 promoter, BamHI downstream of the RNAi cloning site and ScaI in the ampicillin-resistance gene; all of these sites are unique in this
plasmid.TomakeaknockdownvectorthattargetsbothSmad2and-3,pcPUR+U6-Smad2iwasdigestedwithBamHIandScaIandpcPUR+U6-Smad3iwasdigested
withBglIIandScaI.Thefragmentscontainingexpressioncassetteswereligated.(D)Schematicrepresentationofsingle-,double-andtriple-siRNAvectorsgenerated
in this study. pcPUR+U6-Smad4i was described previously (8,9).
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membrane (Amersham, Little Chalfont, UK). The resulting
membrane was dried at room temperature and ﬁxed with
ultraviolet light. The membrane was prehybridized in 30%
formamide, 10% dextran sulfate, 5· SSC, 0.5% SDS, 1·
Denhardt’s solution and 0.2 mg/ml salmon sperm DNA
(Sigma Aldrich, St Louis, MO). Hybridizations were per-
formed at 36 C for 3 h with radiolabeled synthetic oligonu-
cleotide probes that were complementary to the sequences
of siRNAs against Smad2, -3 or -4. A probe complementary
to human tRNA valine was used as a loading control. The
sequences of the probes were as follows:
tRNA valine; 50-GAACGTGATAACCACTACACTACG-
GAAACCCTATAGTGAGTCGTATTAGGCGGGAACC-
GCCTAATACGACTCACTATAGG-30,
Smad2 siRNA; 50-GGATTGAACTTCATCTGAA-30,
Smad3 siRNA; 50-GGATTGAGCTGCACCTGAA-30,a n d
Smad4 siRNA; 50-GTACTTCATACCATGCCGA-30.
The synthetic probes were
32P-labeled (Amersham, Little
Chalfont, UK) using T4 polynucleotide kinase (Takara Shuzo,
Kyoto, Japan). The membrane was washed with 2· SSC twice
at 36 C and analyzed using a Fujix Bio-Image Analyzer
BAS1000 (Fuji Photo Film, Tokyo, Japan).
Luciferase assay
The luciferase assay was performed as described previously
(11,12). Cells were transfected with (CAGA)9-luc or p3TP-
Lux and pRL-SV40. After 24 h, the cells were incubated with
or without 2.5 ng/ml of TGF-b1 (R&D Systems, Minneapolis,
MN) for an additional 24 h, and the dual luciferase assay was
performed. The ﬁreﬂy luciferase activity of (CAGA)9-luc or
p3TP-Lux was normalized to the Renilla luciferase activity of
pRL-SV40. The level of luciferase in cells in the absence of
TGF-b1 was assigned a value of 1.0, and the relative activities
were calculated. The experiments were performed three times
in duplicate.
Quantitative RT–PCR
Quantitative RT–PCR analysis was performed using the ABI
7000 real-time PCR system (Applied Biosystems, Foster City,
CA), as described previously (9). The ratio of the mRNA
level of each gene to that of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was calculated, and the value of
1.0 was assigned to the parental cells. Each experiment was
repeated twice in triplicate. The following primers were used:
BTBD1, forward (50-CAAGGCGTCGCTGAAGGA-30),
reverse (50-CCCAGTACGAAGCGCACAT-30);
prominin 2, forward (50-TGCCCTCTGTGGACCATGT-30),
reverse (50-GGCGTTGAAGGTGCTGTTCT-30);
OAS1, forward (50-AGGTGGTAAAGGGTGGCTCC-30),
reverse (50-ACAACCAGGTCAGCGTCAGAT-30);
GAPDH, forward (50-CCACCCATGGCAAATTCC-30),
reverse (50-TGGGATTTCCATTGATGACAAG-30); and
M13 (for sequence conﬁrmation), reverse (50-CAGGAAA-
CAGCTATGAC-30).
Invasion assay
Invasion was measured using BD BioCoat Matrigel Invas-
ion Chambers (BD Biosciences, San Jose, CA) with 8 mm
diameter, matrigel-coated polycarbonate membrane (8 mm
pore size). A total of 10
5 knockdown or control HaCaT cells
were seeded into the upper chamber of the well. After 24 h, the
cells were incubated in the presence or absence of 5 ng/ml of
TGF-b1 for an additional 24 h. Then, the cells on the upper
surface ofthe ﬁlter were wiped offusingacottonswab, andthe
cells that had invaded the underside of the ﬁlter were ﬁxed,
stained with DiffQuick (Kokusai Shiyaku, Kobe, Japan), and
counted under bright-ﬁeld microscopy at ·200 magniﬁcation
in ﬁve random ﬁelds of view. The experiments were repeated
three times.
Wound closure assay
The wound closure assay was performed as described previ-
ously (9). Conﬂuent cell monolayers were wounded by scrap-
ing using a pipette tip of 1.2 mm width, and incubated with
or without 5 ng/ml of TGF-b1 for 24 h. Cell migration was
carefully observed at various times. The experiments were
repeated three times.
Apoptosis
A total of 2 · 10
6 cells in a 10-cm dish were incubated with
or without 5 ng/ml of TGF-b1 for 24 h, and apoptosis was
analyzed using the ApopTag Fluorescein in situ apoptosis
detection kit S7111 (Serologicals Corporation, Norcross, GA).
A Becton-Dickinson ﬂow cytometer equipped with CellQuest
software was used. The experiments were repeated three times
in duplicate.
RESULTS
Development of double or triple siRNA
expression vectors
We designed four target sites of 21 nt for each of the Smad2,
Smad3 and TGFBR2 (Table 1) genes using software based on
various algorithms for effective siRNA design, as we reported
previously (7,13). To improve silencing activity and to over-
come technical obstacles, such as the frequent mutations that
occur in siRNA constructs or difﬁculties in sequencing
because of tight palindromic sequences, we inserted more
than two C to T or A to G point mutations within the sense
strand of the hairpin (7,14,15). We subcloned chemically syn-
thesized oligonucleotides into the pcPUR+U6-i cassette (6) to
construct siRNA vectors, and we transiently transfected these
siRNA vectors together with Flag-Smad2, Flag-Smad3 or
TGFBR2-HA expression vectors into HeLa cells to test the
silencing efﬁcacy of the siRNA. This method of screening the
optimal sequence for silencing is useful because plasmids
expressing epitope-tagged cDNA and siRNA both tend to
enter the same cells, and western blotting using the antibody
against the epitope tag, not the protein itself, reduces the
background signal of endogenous proteins from non-
transfected cells. Two of four sites in Smad2, three of four
in Smad3 and all sites in TGFBR2 were effective in suppress-
ing their targets down to 0–10% (Figure 1A). For further
knockdown constructs, we selected site 1 for Smad2, site 2
for Smad3 and site 1 for TGFBR2, which proved to be most
effective. The constructs containing these sites were named
pcPUR+U6-Smad2i, pcPUR+U6-Smad3i and pcPUR+U6-
TGFBR2i (Figure 1A) to knock down the Smad2, Smad3
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ysis, we conﬁrmed that the knockdown of Smad2 and Smad3,
which are highly homologous proteins, does not exert a mutual
effect (Figure 1B). We succeeded in obtaining single knock-
down vectors against Smad2, Smad3 and TGFRB2.
Next, we attempted to make knockdown vectors against
multiplegenesbycombiningtheseconstructs.ThepcPUR+U6
vector has restriction enzyme sites of BglII upstream of the U6
promoter, a BamHI site downstream of the RNAi sequence
and a ScaI site in the ampicillin gene; all of these sites are
unique in this plasmid. To make a knockdown vector that tar-
gets Smad2 and Smad3 simultaneously, we digested pcPUR+
U6-Smad2i with BamHI and ScaI and digested pcPUR+
U6-Smad3i with BglII and ScaI (Step 1 in Figure 1C), and
fragments containing expression cassettes were ligated to
make a single vector that knocked down both Smad2 and
Smad3 (Steps 2 and 3 in Figure 1C). The constructs against
Smad2 and -3, Smad2 and -4, and Smad3 and -4 were named
pcPUR+U6-Smad2/3i, pcPUR+U6-Smad2/4i and pcPUR+
U6-Smad3/4i, respectively (Figure 1D). Knockdown vector
pcPUR+U6-Smad2/3/4i, targeting all pathway-related Smads
(Smad2, Smad3 and Smad4), was generated by the same pro-
cedure (Figure 1D). The advantage of this system is that sites
produced by BglII and BamHI are cohesive but cannot be cut
after ligation, and so the same procedure is repeatable to make
target vectors against multiple genes. Also, the unique ScaI
site in the ampicillin-resistance gene contributes to the reduc-
tion of the number of background bacterial colonies.
Validating the Smads knockdown
To test the efﬁcacy of these vectors, we used a human ker-
atinocyte cell line, HaCaT, which has a functional TGF-b
pathway, for further analysis. This cell line is suitable for
the analysis of TGF-b signaling (16). HaCaT was transfected
with these vectors and selected with 1 mg/ml of puromycin
to obtain stable knockdown cell lines S2KD, S3KD, S4KD,
S23KD,S24KD,S34KD,S234KDandiGFP,respectively.We
used stable cell pools, which are mixtures of the puromycin-
resistant polyclonal cells, not independent cell clones, to
exclude any cellular changes owing to genomic integration
of the plasmid. As shown in Figure 2A, most of the stable
transformants (lanes 2–8) exhibited a drastic reduction of
endogenous Smad2, Smad3 and Smad4 protein expression.
Although S234KD cells harbor three different siRNAs, the
method resulted in an excellent knockdown of their intended
targets. Northern analysis showed that the same amount of
siRNA against Smad2, Smad3 or Smad4 was stably expressed
inallsingle,double ortripleknockdown cells (Figure 2B). The
expression of endogenous Smads or siRNAs in the original
cell stock and cells after 20 passages from the original stock
wastestedusingwestern ornorthernblotting,respectively,and
no signiﬁcant changes in the Smad protein levels or siRNA
expression were observed after 20 passages (data not shown).
Because one of the potential problems of using polyclonal cell
pools is a change in the clonality of cells after multiple pas-
sages, we performed biological assays using cells within ﬁve
passages of the original stock vials as described in Materials
and Methods. We were unable to obtain a stable TGFBR2
knockdown cell line because massive cell death occurred
after the transfection, suggesting that TGFBR2 is important
for cell survival in this cell line. The silencing efﬁciency did
not depend on the location along the vector or the number of
siRNAs, up to three (data not shown).
Some 11–15 contiguous nucleotides of sequence identity
with siRNA were reportedly sufﬁcient to direct the silencing
of non-targeted messenger RNA (mRNA) transcripts (17).
Although we carefully selected the target sequence by using
original algorithms that omit any sequences that are highly
homologous to other genes (7,13), we could not exclude the
possibility of knocking down non-speciﬁc genes. To examine
off-target gene silencing in our cells, we used the BLAST
database (http://www.ncbi.nlm.nih.gov/BLAST) to search
the human genome for any complementary sequences with
at least 11 contiguous nucleotides matching the RNAi sites
we used. For TGFBR2 site 1, no gene appeared to have
sequence similarity. For Smad2 site 1, a BTB/POZ domain-
containing one protein (BTBD1) had 17 contiguous nucleotide
matches, and some other hits had less similarity. A pentaspan
membrane glycoprotein (prominin 2) had 15 contiguous
nucleotides similar to Smad3 site 2. We examined their
mRNA expressions in knockdown cells by using quantitative
RT–PCR. As their expressions were not reduced in S2KD or
S3KD cells compared with parental HaCaT cells (Figure 2C
and D) or the iGFP control cell line (data not shown), we
conclude that there was no off-target gene silencing in estab-
lished cell lines. Another report demonstrated that the inter-
feron response was induced by U6 promoter/lentivirus shRNA
constructsinmammaliancells(18).Thea/binterferonsinduce
a double-stranded RNA (dsRNA)-binding enzyme, OAS1,
which is activated in a dsRNA-dependent manner. Although
our constructs were not derived from lentivirus, we checked
the OAS1 inductionto rule out any non-speciﬁcRNA degrada-
tion. Theoretically, triple-knockdown cells that might produce
moresiRNAsarelikelytoinducemoreOAS1,buttherewasno
statistical difference of OAS-1 mRNA among knockdown cell
lines and the parental HaCaT cell line (Figure 2E) or iGFP
control cell line (data not shown). The pcPUR+U6 constructs
appear to be highly speciﬁc against target genes and effective
for gene silencing, and thus we proceeded to functional anal-
ysis of the TGF-b pathway in these cells.
Luciferase assays using the Smad-dependent reporter
(CAGA)9-luc showed that the canonical TGF-b-Smad-
dependent signaling was markedly inhibited in all cell lines
except S2KD (Figure 2F). The preserved induction of
luciferase in S2KD cells by TGF-b (Figure 2F) is in agreement
with the original report (10) in which Smad3 and Smad4, but
not Smad2, bound to this Smad-binding element. The induc-
tion of the luciferase activity of S2KD cells by TGF-b was
downregulated to 20% of that of control cells when p3TP-Lux
(three TRE elements from the human collagenase gene linked
to the  740/ 636 region of the PAI-1 promoter, which is
selectively induced by TGF-b) was used as the reporter
plasmid (data not shown). We investigated the induction of
PAI-1, a well-known TGF-b-responsive gene, in knockdown
cell lines. The results revealed that TGF-b-mediated PAI-1
induction was impaired in all knockdown cell lines, except
for the S2KD cell line (Figure 2G). TGF-b-mediated PAI-1
induction is largely dependent on the CAGA Smad binding
element in its promoter region, and the results of the PAI-1
western blot were consistent with the reporter assay shown in
Figure 2F.
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Past knowledge of the functional differences of Smad proteins
has been accumulated by using Smad dominant-negative con-
structs (19), antisense RNA (20) and siRNA duplexes (21).
These studies focused mainly on molecular targets or changes
in signal transduction rather than phenotypic changes because
the transient nature of these previous methods limited such
observations. In contrast, stable RNAi constructs allowed us to
concentrate more on changes in TGF-b-dependent phenotypes
such as invasion, wound closure and apoptosis.
Using matrigel invasion chambers, we analyzed the TGF-b-
dependent invasion in vitro. Although there are reports that
the loss of Smad4 in mice leads to increased metastasis and
tumor invasion (2,22), our results show that the invasive activ-
ity of S4KD cells without TGF-b is lower than that of any
other cells, and that TGF-b strongly stimulates invasion (41.3-
fold increase; Figure 3A and B). S2KD and S3KD cells, in
contrast, have invasive character at the base level, but respond
to TGF-b poorly (8.3- and 3.5-fold increases, respectively).
TheTGF-b-dependentinvasionofS23KD,S24KDandS34KD
cells had no statistically signiﬁcant differences compared
with that of control iGFP cells (4.3-, 4.3-, 3.8- and 3.8-fold
increases, respectively). The fold increase in the TGF-b-
induced invasion in S4KD cells was more than 10 times
that of control cells with intact Smad4 (Figure 3A and B).
Invasion induced by TGF-b was statistically and signiﬁcantly
Figure 2. Efficiency and specificity of stable knockdown cells. (A) Endogenous Smad knockdown. HaCaT cells were transfected with pcPUR+U6-GFPi,
pcPUR+U6-Smad2i, pcPUR+U6-Smad3i, pcPUR+U6-Smad4i, pcPUR+U6-Smad2/3i, pcPUR+U6-Smad2/4i, pcPUR+U6-Smad3/4i or pcPUR+U6-Smad2/3/4i
andincubatedwith1mg/mlofpuromycintoselectstablytransfectedcells.Thetotalcelllysatesweresubjectedtowesternblotanalysis.(B)TheexpressionofsiRNAs
(21nt)againstSmad2,-3or-4incellswasdetectedusingnorthernblotanalysis.tRNAvalinewasusedasacontrol.(CandD)Knockdownvectorsdonottriggernon-
specifictargetgenesilencingor(E)interferoninduction.Relativeexpressionsof(C)BTBD1,(D)prominin2or(E)OAS1intheindicatedcelllineswereassessedby
quantitativeRT–PCR.ThegeneexpressionlevelintheparentalHaCaTcellswasassignedavalueof1.0.(F)InhibitionofTGF-b-Smadsignalinginknockdowncells.
Theknockdownandcontrolcellsweretransfectedwith(CAGA)9-lucandpRL-SV40.After24h,thecellswereincubatedwithorwithout2.5ng/mlofTGF-b1foran
additional24h,andthedualluciferaseassaywasperformed.Thefireflyluciferaseactivityof(CAGA)9-lucwasnormalizedtotheRenillaluciferaseactivityofpRL-
SV40.ThelevelofluciferaseinthecellsintheabsenceofTGF-b1wasassignedavalueof1.0(openbars),andtherelativeactivitieswerecalculated.Theexperiments
were performed three times in duplicate, and the mean and standard error are shown. (G) Induction of PAI-1 by TGF-b was examined by western blot. Cells were
incubated with or without 5 ng/ml TGF-b for 10 h, and total cell lysates were prepared.
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compared with that of Smad4 knockdown cells, suggest-
ing that Smad2 and Smad3 are important for TGF-b-
mediated cell invasion in cells lacking the function of Smad4.
As TGF-b is known to promote wound closure by activating
cell migration, we tested the ability of TGF-b to induce
wound closure in established knockdown cell lines. Conﬂuent
cell monolayers were wounded with a tip of 1.2-mm width,
and wound closure was observed after 24 h of TGF-b
administration. In our earlier report, Smad4 knockdown
blocked wound closure induced by TGF-b in Panc-1 cells
(9); we observed similar results in HaCaT cells. As shown
in Figure 3C and D, the loss of Smad3 alone or together with
Smad2 or Smad4 accelerated wound closure, a ﬁnding that is
consistent with the reports in Smad3-knockout mice (23). In
contrast, S2KD and S234KD cells had attenuated wound clo-
sure compared with that of control cells (Figure 3C and D).
Although all Smads are downstream mediators of the same
TGF-b pathway, each Smad seems to contribute differently to
cell migration.
Figure 3. AnalysisofTGF-b-dependent cellularphenotypesofstableknockdowncell lines. (A) Representative imagesof the invasionassay and(B) the numberof
invaded cells. The numbers of cells that invaded through the matrigel in the absence (open bars) and presence (closed bars) of TGF-b were counted in five random
fields of view. The experiments were repeated three times, and the mean and standard errors are shown. (C) Representative images of the migration assay. Wound
closure was assessed after 24 h with or without 5 ng/ml of TGF-b1.( D) Percentage of distance between wound edges in the absence (open bars) or presence (closed
bars) of TGF-b1 in the indicated cell lines. The experiments were performed three times, and the mean and standard errors are shown. (E) Percentages of apoptotic
cells in the absence (open bars) or presence (closed bars) of 5 ng/ml of TGF-b1 for 24 h are shown. Three independent experiments were performed with similar
results, and the representative results are shown.
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depending on cell type (2). In HaCaT cells, TGF-b enhances
survival by preventing apoptosis via the Akt-dependent regu-
lation of FKHRL1 (24). We tested whether this ability of
TGF-bwasaffectedbydisruption ofitsdownstreamregulators
(Figure 3E). The percentages of apoptotic cells for different
cell types in the absence/presence of TGF-b were as follows:
iGFP, 0.21/0.15; S2KD, 0.61/1.01; S3KD, 1.64/1.78; S4KD,
0.29/0.31; S23KD, 1.41/2.50; S24KD, 1.47/2.5; S34KD, 1.48/
1.31; and S234KD, 1.42/12.32. To our surprise, TGF-b still
prevented apoptosis in single- or double-knockdown cells.
When we knocked down all Smads (Smad2, Smad3 and
Smad4), TGF-b lost its apoptosis-preventing function and
gained an apoptosis-inducing function. As the underlying
mechanism is unknown, our data suggest that in this cell
line, the Smad-independent TGF-b pathway transmits apop-
totic signals in the absence of all Smads.
DISCUSSION
RNAi is arguably one of the great discoveries of humankind
(25–27). Despite substantial improvements in making effec-
tive siRNA duplexes (14,15), many biologists still have dif-
ﬁculty performing efﬁcient RNAi owing to low transfection
efﬁciency and the frequent cytotoxicity associated with
the transfection method (5). The development of vector-
expressed siRNA represents revolutionary progress (6,28).
Although some robust techniques for generating large-scale
RNAi libraries have been introduced (7,29), they are costly,
time-consuming and optimization is needed for the stable
knockdown of multiple genes to similar levels in the same
cells. Besides large-scale RNAi library screening, researchers
in a particular ﬁeld also need a more pinpointable, multiple
stable knockdown method for a particular analysis, without
using different selection antibiotics, and we believe that our
newly established method fulﬁlls these requirements. A recent
study stated that small hairpin RNA Dicer substrates were
more effective in promoting RNAi than siRNA duplexes
(30). The results could position the shRNA expressing vectors
as a dominant tool for RNAi analysis in the future.
The method described here is a rapid, simple and effective
way to produce stable RNAi cell lines. In this report, we
demonstrate the efﬁciency of this method for silencing at
least three targets side by side. Although they are different
techniques, multiple knockout mouse models and multiple
stable RNAi share a common feature of stably suppressing
gene expression. As the former has contributed enormously to
the life sciences, we expect as much from the latter. The RNAi
machinery is a multiple-turn enzyme complex, so once acti-
vated, a single RISC complex could potentially cleave many
copies of RNA targets (31), and this feature could allow effec-
tive silencing of multiple targets simultaneously. If an effec-
tive shRNA fails to work because of the low concentration
of shRNAs produced, it may be possible to achieve efﬁcient
knockdown by doubling, quadrupling or further increasing
the copy number of RNAi cassettes by combining the same
plasmid. This advantage of this system is very important
because it increases the number of shRNAs without signiﬁ-
cantly changing the overall plasmid length. Hypothetically,
a single siRNA expression plasmid could harbor >30 shRNA
cassettes, if the upper length for successful plasmid DNA
transfection is 20 kb. Further experimentation is necessary
to determine the maximum number of targets that can be
silenced effectively.
In transient transfection experiments, a major drawback
of RNAi could result from the elevated level of siRNA trans-
cription, which could saturate the siRNA machinery and
contribute to unwanted effects. The idea that large amounts
ofsiRNA inside a transfected cellcouldimprove the efﬁciency
ofgene silencingremainstobe veriﬁed. Although we followed
the stability of siRNA until 20 passages of cell culture in
various cell lines and observed no apparent loss of siRNA
in any cell line, these stable cell lines should be carefully
followed over the long term to check the biological conse-
quences of these vectors.
In this study, we found phenotypic changes in cells lacking
Smads. As shown here, there are discrepancies in the results
of biological assays, and the changes were complex, which
suggeststhatthe knockdownofSmadsaffects theregulationof
other signaling pathways. Previous papers, including ours
(8,9), suggest the existence of Smad-independent pathways,
such as the MAPK, RhoA, PP2A and TAK1/MEKK pathways.
To dissect the biological response to TGF-b at the molecular
level, future investigation is needed.
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